Abstract 139: PARP-1 Silencing Upregulates FOSL1 Transcription, Enhances Angiogenesis and Accelerates Ischemic-Diabetic Wound Healing

Autor: Bao Nguyen, Divya Cheedu, Raul Sebastian, Robyn Mascata, Jaideep Banerjee, Anton N. Sidawy, Lopa Mishra
Rok vydání: 2018
Předmět:
Zdroj: Arteriosclerosis, Thrombosis, and Vascular Biology. 38
ISSN: 1524-4636
1079-5642
DOI: 10.1161/atvb.38.suppl_1.139
Popis: Objective: People with combined ischemic and diabetic wounds of the lower extremities have the highest risk for limb loss, especially for those without surgical revascularization options. We have demonstrated that Poly-ADP-Ribose polymerase (PARP-1) is hyperactivated in hyperglycemic/hypoxic cells and in ischemic/diabetic murine wounds. This study elucidates the molecular mechanisms of PARP-1 mediated impairment of angiogenesis in diabetic/ischemic wounds. Methods: A model of dorsal bipedicle flap-ischemic wounds on diabetic mice was used. The wounds were treated topically with nanoparticle-encapsulated siPARP-1 or vehicle. Wound closure rate and perfusion was analyzed using digital photography and Laser Doppler scanning, respectively. Angiogenetic markers in the tissues were measured by immunohistochemistry. In-vitro endothelial tube formation assay was performed using HUVECs cultured under hyperglycemic and hypoxic conditions. Results: Wounds treated with topical siPARP-1 significantly accelerated wound healing compared to vehicle (from 25% ± 5% to 40%± 8% ( n =7, p < .05) by day 6 and from 50% ± 15% to 75%± 3% ( n =7, p < .05) by day 12, and also exhibited improved tissue perfusion (50%± 5% increase in perfusion units over control on day 6, n =47 p n =4, p n =4, p n =4, p n =4, p Conclusions: PARP-1 silencing is an effective strategy to promote ischemic-diabetic wound healing. Our data suggest that PARP-1-FOSL1 is a potential novel axis in angiogenesis and PARP-1 could be a promising therapeutic target for improving angiogenesis in these wounds.
Databáze: OpenAIRE
Externí odkaz: